首页> 外文期刊>Fitoterapia >Long-term treatment with standardized Ginkgo biloba Extract (EGb 761) attenuates cognitive deficits and hippocampal neuron loss in a gerbil model of vascular dementia
【24h】

Long-term treatment with standardized Ginkgo biloba Extract (EGb 761) attenuates cognitive deficits and hippocampal neuron loss in a gerbil model of vascular dementia

机译:标准化的银杏叶提取物(EGb 761)的长期治疗可减轻血管性痴呆的沙鼠模型中的认知缺陷和海马神经元丧失

获取原文
获取原文并翻译 | 示例
           

摘要

The standardized extract of Ginkgo biloba EGb 761 has been used to reduce cognitive dysfunction. The present study was designed to evaluate the effect of postischemic oral treatment with EGb 761 in a model of vascular dementia in gerbils. Daily oral posttreatment with EGb 761 led to a significant recovery of spatial memory assessed by the object location test, inhibited the decrease in plasma SOD activity and protected the hippocampal CA1 neurons, even when administered after the insult. These data provide further evidence for the therapeutic potential of EGb 761 in the treatment of vascular dementia
机译:银杏叶银杏叶提取物761的标准化提取物已用于减少认知功能障碍。本研究旨在评估在沙鼠的血管性痴呆模型中,EGB 761缺血后口服治疗的效果。每天进行口服EGb 761口服后处理,可通过对象定位测试评估其空间记忆的显着恢复,即使在受伤后给药,也可抑制血浆SOD活性的下降并保护海马CA1神经元。这些数据为EGB 761在治疗血管性痴呆中的治疗潜力提供了进一步的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号